Table 1.
Patient characteristics.
| All cases | non-COVID | COVID-19 | |
|---|---|---|---|
| n | 24 | 9 | 15 |
| Age | 63.2 (27–95) | 55.6 (27–74) | 67.8 (30–95) |
| Male sex | 14 (58) | 6 (67) | 8 (53) |
| Duration of symptoms (days)a | 14.3 (5–49) | N/A | 14.3 (5–49) |
| Duration of hospitalization (days) | 9.1 (0–52) | N/A | 9.1 (0–52) |
| History of cardiovascular diseases | |||
| HTN | 16 (67) | 5 (56) | 11 (73) |
| DM | 12 (50) | 3 (33) | 9 (60) |
| HL | 10 (42) | 1 (11) | 9 (60) |
| NSTEMI | 1 (4) | 0 | 1 (7) |
| congenital heart | 1 (4) | 0 | 1 (7) |
| Prior atrial fibrillation | 1 (7) | N/A | 1 (7) |
| New-onset atrial fibrillation | 2 (13) | N/A | 2 (13) |
| New ECG changes | 8(53) | N/A | 8 (53) |
| Peak troponin (ng/mL)b | 4.2 (0.00–93.85) | N/A | 4.2 (0.00–93.85) |
| Drug treatment | |||
| HCQ/CQ | 8 (53) | N/A | 8 (53) |
| Steroids | 2 (13) | N/A | 2 (13) |
| Antibiotics | 12 (80) | N/A | 12 (80) |
| Anticoagulation | 10 (67) | N/A | 10 (67) |
Data are expressed as median (range) or n (%).
a
From onset of symptoms to death
b
Highest troponin value if multiple troponin values were available.